August 30, 2023
In a significant development for the cannabis industry, U.S. health officials have recommended easing restrictions on cannabis and reclassifying it as a Schedule III drug under the Controlled Substances Act. The move could open the door to more cohesive payments systems in the sector. Currently, cannabis is classified as a Schedule I substance, which implies […]
